BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed LQDA catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:b6097d56d8722bf8accd@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:LQDA P2 readout (est.): RE-WARM
DESCRIPTION:A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemi
 c Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks\nNCT07748000
  | PHASE2 | NOT_YET_RECRUITING | sponsor: Liquidia Technologies\, Inc.\nPr
 imary completion date (ESTIMATED)\; top-line results usually follow later.
 \nDate precision: month (shown on the first day)\nTicker LQDA (confidence 
 0.6)\nSource: https://clinicaltrials.gov/study/NCT07748000\nScheduling/ref
 erence data from public records\; dates can move. Not investment\, legal o
 r medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT07748000
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
